Interpreting very low Mycobacterium tuberculosis detected on Xpert Mycobacterium tuberculosis/rifampicin

The development and rollout of the Xpert(®) Mycobacterium tuberculosis/rifampicin assay for the GeneXpert platform is considered an important breakthrough in the fight against tuberculosis. Xpert though robust is known to have issues that occur with very low load of tuberculosis detection, wherein i...

Descripción completa

Detalles Bibliográficos
Autores principales: Ajbani, Kanchan, Naik, Swapna, Kazi, Mubin, Shetty, Anjali, Rodrigues, Camilla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
General Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852221/
https://www.ncbi.nlm.nih.gov/pubmed/31670308
http://dx.doi.org/10.4103/lungindia.lungindia_463_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852221/
https://www.ncbi.nlm.nih.gov/pubmed/31670308
http://dx.doi.org/10.4103/lungindia.lungindia_463_18

Ejemplares similares